Ghazanfari S, Imenshahidi M, Etemad L, Moshiri M, Hosseinzadeh H
Department of Pharmacodynamy and Toxicology, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, IR. Iran.
Drug Res (Stuttg). 2014 Mar;64(3):113-7. doi: 10.1055/s-0033-1355364. Epub 2013 Oct 8.
The antinociceptive effect of cyanocobalamin (Vit B12) has been reported in animal models and human studies. Our previous study showed the effect of Vit B12 on morphine tolerance. The dependence and tolerance were induced in male mice using subcutaneous morphine injections, 3 times a day (50, 50 and 75 mg/kg/day) for 3 days. Mice also received Vit B12 (100, 250 and 500 µg/kg), clonidine, memantine and saline intraperitoneally before morphine administration. On fourth day mice received only 7 mg /kg morphine just before tail-flick test. To determine the expression of morphine dependence and tolerance, all compounds were injected once intraperitoneally on the day of experiment. The tolerance was evaluated by the tail-flick test. The effect of Vit B12 and other agents on dependence were evaluated by counting the number of jumps (induced by naloxone 5 mg/kg). Co-administration of Vit B12 (100-500 µg/kg) and morphine in 3 days reduced the development of tolerance to morphine analgesic effect (8.2±0.5 and 7.83±0.5 s. vs. normal saline, 3.57±0.3 s). Repeated administration of Vit B12, also, diminished the reduced naloxane withdrawal signs of naloxone withdrawal test (100-500 µg/kg: 5±1.9 and 1.2±0.8 jumps vs. normal saline 72.6±12.2). However, Vit B12 had no effect on the expression of morphine tolerance and physical dependence. It is concluded that co-administration of Vit B12 and morphine could reduce tolerance to analgesic effect of morphine chronic administration and also reduce its withdrawal symptoms.
在动物模型和人体研究中均已报道了氰钴胺(维生素B12)的抗伤害感受作用。我们之前的研究显示了维生素B12对吗啡耐受性的影响。通过皮下注射吗啡诱导雄性小鼠产生依赖性和耐受性,每天3次(50、50和75mg/kg/天),持续3天。在给予吗啡前,小鼠还腹腔注射了维生素B12(100、250和500μg/kg)、可乐定、美金刚和生理盐水。在第4天,小鼠在甩尾试验前仅接受7mg/kg吗啡。为了确定吗啡依赖性和耐受性的表达,所有化合物在实验当天均腹腔注射一次。通过甩尾试验评估耐受性。通过计算跳跃次数(由5mg/kg纳洛酮诱导)评估维生素B12和其他药物对依赖性的影响。连续3天联合给予维生素B12(100 - 500μg/kg)和吗啡可降低对吗啡镇痛作用的耐受性发展(分别为8.2±0.5和7.83±0.5秒,与生理盐水组3.57±0.3秒相比)。重复给予维生素B12也减少了纳洛酮戒断试验中纳洛酮戒断症状的减轻(100 - 500μg/kg:分别为5±1.9和1.2±0.8次跳跃,与生理盐水组72.6±12.2次相比)。然而,维生素B12对吗啡耐受性和身体依赖性的表达没有影响。结论是,联合给予维生素B12和吗啡可降低对吗啡慢性给药镇痛作用的耐受性,并减轻其戒断症状。